Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Rheumatoid Arthritis

Free Subscription Articles published in Ann Rheum Dis Retrieve available abstracts of 264 articles: HTML format Text format

Single Articles

February 2010
1. MARINOU I , Maxwell JR, Wilson AG
   Genetic influences modulating the radiological severity of rheumatoid arthritis.
   Ann Rheum Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. DOLHAIN RJ
   Rheumatoid arthritis and pregnancy; not only for rheumatologists interested in female health issues.
   Ann Rheum Dis. 2010;69:317-8.
   PubMed     Text format     Related articles   
   
   
   
3. LASKARIA K , Ahmadi-Simab K, Lamken M, Csernok E, et al
   Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis?
   Ann Rheum Dis. 2010;69:469-71.
   PubMed     Text format     Related articles   
   
   
   
4. NAUMANN L , Feist E, Natusch A, Langen S, et al
   IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
   Ann Rheum Dis. 2010;69:466-7.
   PubMed     Text format     Related articles   
   
   
   
5. GREENBERG JD , Reed G, Kremer JM, Tindall E, et al
   Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.
   Ann Rheum Dis. 2010;69:380-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. FREESTON JE , Wakefield RJ, Conaghan PG, Hensor EM, et al
   A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools.
   Ann Rheum Dis. 2010;69:417-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. JONES E , Churchman SM, English A, Buch MH, et al
   Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level.
   Ann Rheum Dis. 2010;69:450-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. GULFE A , Kristensen LE, Saxne T, Jacobsson LT, et al
   Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden.
   Ann Rheum Dis. 2010;69:352-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. DELGADO-VEGA AM , Castiblanco J, Gomez LM, Diaz-Gallo LM, et al
   Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women.
   Ann Rheum Dis. 2010;69:462-5.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
10. MOMOHARA S , Inoue E, Ikari K, Kawamura K, et al
    Decrease in orthopaedic operations, including total joint replacements, in patients with rheumatoid arthritis between 2001 and 2007: data from Japanese outpatients in a single institute-based large observational cohort (IORRA).
    Ann Rheum Dis. 2010;69:312-3.
    PubMed     Text format     Related articles   
    
    
    
11. BOERS M
    A new design for registration trials in rheumatoid arthritis allowing secondary head-to-head comparisons with standard of care treatment including biologicals.
    Ann Rheum Dis. 2010;69:4-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MCHUGH KP , Shen Z, Crotti TN, Flannery MR, et al
    The role of cell-substrate interaction in regulating osteoclast activation: potential implications in targeting bone loss in rheumatoid arthritis.
    Ann Rheum Dis. 2010;69 Suppl 1:i83-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. GABRIEL SE
    Heart disease and rheumatoid arthritis: understanding the risks.
    Ann Rheum Dis. 2010;69 Suppl 1:i61-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. VAN ZONNEVELD AJ , de Boer HC, van der Veer EP, Rabelink TJ, et al
    Inflammation, vascular injury and repair in rheumatoid arthritis.
    Ann Rheum Dis. 2010;69 Suppl 1:i57-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. HAUPL T , Stuhlmuller B, Grutzkau A, Radbruch A, et al
    Does gene expression analysis inform us in rheumatoid arthritis?
    Ann Rheum Dis. 2010;69 Suppl 1:i37-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
16. STOLT P , Yahya A, Bengtsson C, Kallberg H, et al
    Silica exposure among male current smokers is associated with a high risk of developing ACPA positive rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. PAVY S , Toonen EJ, Miceli-Richard C, Barrera P, et al
    TNF alpha -308 G>A polymorphism is not associated with response to TNF-alpha-blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. NAUMANN L , Huscher D, Detert J, Spengler M, et al
    Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment.
    Ann Rheum Dis. 2009;68:1934-6.
    PubMed     Text format     Related articles   
    
    
    
19. STRAND V , Crawford B, Singh J, Choy E, et al
    Use of "spydergrams" to present and interpret SF-36 health-related quality of life data across rheumatic diseases.
    Ann Rheum Dis. 2009;68:1800-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. VLIET VLIELAND TP , Huizinga TW
    Quality indicators in rheumatology: valid for whom?
    Ann Rheum Dis. 2009;68:1797-9.
    PubMed     Text format     Related articles   
    
    
    November 2009
21. EYRE S , Hinks A, Flynn E, Martin P, et al
    Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. EMERY P , Durez P, Dougados M, Legerton CW, et al
    The impact of T-cell co-stimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. VAN EIJK IC , Tushuizen ME, Sturk A, Dijkmans BA, et al
    Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. SENOLT L , Polanska M, Filkova M, Oslejskova L, et al
    Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. SMULDERS E , Schreven C, Weerdesteyn V, van den Hoogen FH, et al
    Fall incidence and fall risk factors in people with rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1795-6.
    PubMed     Text format     Related articles   
    
    
    
26. MURASHIMA A , Watanabe N, Ozawa N, Saito H, et al
    Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum.
    Ann Rheum Dis. 2009;68:1793-4.
    PubMed     Text format     Related articles   
    
    
    
27. KURREEMAN FA , Daha NA, Chang M, Catanese JJ, et al
    Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population.
    Ann Rheum Dis. 2009;68:1789-90.
    PubMed     Text format     Related articles   
    
    
    
28. BERGER CT , Recher M, Steiner U, Hauser TM, et al
    A patient's wish: anakinra in pregnancy.
    Ann Rheum Dis. 2009;68:1794-5.
    PubMed     Text format     Related articles   
    
    
    
29. FELDMAN DE , Schieir O, Montcalm AJ, Bernatsky S, et al
    Rapidity of rheumatology consultation for people in an early inflammatory arthritis cohort.
    Ann Rheum Dis. 2009;68:1790-1.
    PubMed     Text format     Related articles   
    
    
    
30. CARMONA L , Loza E
    Despair on disparities.
    Ann Rheum Dis. 2009;68:1657-8.
    PubMed     Text format     Related articles   
    
    
    October 2009
31. MYASOEDOVA E , Crowson CS, Maradit-Kremers H, Fitz-Gibbon PD, et al
    Total cholesterol and LDL levels decrease before rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. TOMS TE , Panoulas VF, Douglas KM, Griffiths H, et al
    Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial under treatment of lipid associated cardiovascular risk?
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. NIKOLAUS S , Bode C, Taal E, van de Laar MA, et al
    New insights into the experience of fatigue among patients with rheumatoid arthritis: a qualitative study.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. DIXON WG , Hyrich KL, Watson KD, Lunt M, et al
    Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR).
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. OKADA Y , Suzuki A, Yamada R, Kochi Y, et al
    HLA-DRB1*0901 lowers anti-cyclic citrullinated peptide antibody levels in Japanese patients with rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. RADNER H , Smolen JS, Aletaha D
    The impact of comorbidity on physical function in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. VAN TUYL LH , Lems WF, Kerstens PJ, Voskuyl AE, et al
    IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1652-3.
    PubMed     Text format     Related articles   
    
    
    September 2009
38. LANDEWE RB , Houbiers JG, Van den Bosch FE, In 't Hout J, et al
    Intranasal administration of recombinant Human Cartilage glycoprotein-39 as a treatment for rheumatoid arthritis: A Phase II, multicenter, double-blind, randomized, placebo-controlled, parallel group dose-finding trial.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. BALDWIN HM , Ito-Ihara T, Isaacs JD, Hilkens CM, et al
    TNF{alpha} blockade impairs dendritic cell survival and function in rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. PETERS MJ , Symmons DP, McCarey D, Dijkmans BA, et al
    EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. BOERS M
    The time has come to limit the placebo period in rheumatoid arthritis trials to 3 months: A systematic comparison of 3- and 6-month response rates in trials of biologic agents.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. DOUGADOS M , Jousse-Joulin S, Mistretta F, D'Agostino MA, et al
    Evaluation of several ultrasonography scoring systems of synovitis and comparison to clinical examination: Results from a prospective multi-center study of rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. LIE E , van der Heijde DM, Uhlig T, Heiberg MS, et al
    The effectiveness and retention rates of methotrexate in psoriatic arthritis with methotrexate treated patients with rheumatoid arthritis as a reference population.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. ITO I , Kawasaki A, Ito S, Kondo Y, et al
    Replication of association between FAM167A(C8orf13)-BLK region and rheumatoid arthritis in a Japanese population.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. DORE RK , Cohen SB, Lane NE, Palmer WR, et al
    Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. SKINNINGSRUD B , Lie BA, Husebye ES, Kvien TK, et al
    A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-CCP negative rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. PRIORI R , Alessandri C, Magrini L, Cassara EA, et al
    Nucleosome accumulation and reduction of C-reactive protein are associated with the generation of anti-nuclear antibodies in patients with rheumatoid arthritis treated with adalimumab, but not with etanercept.
    Ann Rheum Dis. 2009;68:1514-6.
    PubMed     Text format     Related articles   
    
    
    
48. VOORZANGER-ROUSSELOT N , Ben-Tabassi NC, Garnero P
    Opposite relationships between circulating Dkk-1 and cartilage breakdown in patients with rheumatoid arthritis and knee osteoarthritis.
    Ann Rheum Dis. 2009;68:1513-4.
    PubMed     Text format     Related articles   
    
    
    
49. URSUM J , Britsemmer K, van Schaardenburg D, Lips PT, et al
    High prevalence of vertebral deformities in elderly patients with early rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1512-3.
    PubMed     Text format     Related articles   
    
    
    
50. STEEN KS , Lems WF, Visman IM, Heierman M, et al
    High incidence of cardiovascular events in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1509-10.
    PubMed     Text format     Related articles   
    
    
    
51. MBAREK H , Kallel-Sellami M, Zerzri Y, Dawidowicz K, et al
    New rheumatoid arthritis genetic factor and C5 serum level.
    Ann Rheum Dis. 2009;68:1508-9.
    PubMed     Text format     Related articles   
    
    
    
52. BOUQUILLARD E , Combe B
    Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases.
    Ann Rheum Dis. 2009;68:1505-6.
    PubMed     Text format     Related articles   
    
    
    
53. BINARD A , Le Pottier L, Devauchelle-Pensec V, Saraux A, et al
    Is the blood B-cell subset profile diagnostic for Sjogren syndrome?
    Ann Rheum Dis. 2009;68:1447-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. MARINOU I , Walters K, Dickson MC, Binks MH, et al
    Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1494-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
55. SMOLEN JS , Aletaha D, Grisar JC, Stamm TA, et al
    Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trials.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. WALLENIUS M , Skomsvoll JF, Irgens L, Salvesen KA, et al
    Post partum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. HINKS A , Eyre S, Ke X, Barton A, et al
    Overlap of disease susceptibility loci for rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA).
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. PLANT D , Barton A, Thomson W, Ke X, et al
    A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1373-5.
    PubMed     Text format     Related articles   
    
    
    
59. KOLLING C , Herren DB, Simmen BR, Goldhahn J, et al
    Changes in surgical intervention patterns in rheumatoid arthritis over 10 years in one centre.
    Ann Rheum Dis. 2009;68:1372-3.
    PubMed     Text format     Related articles   
    
    
    
60. VAN DEN BEMT BJ , Vos K, den Broeder AA, Blom M, et al
    A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1368-9.
    PubMed     Text format     Related articles   
    
    
    
61. GRABAR PB , Rozman B, Logar D, Praprotnik S, et al
    Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1367-8.
    PubMed     Text format     Related articles   
    
    
    
62. VAN VOLLENHOVEN RF
    How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
    Ann Rheum Dis. 2009;68:1237-9.
    PubMed     Text format     Related articles   
    
    
    
63. KOOLOOS WM , Wessels JA, van der Kooij SM, Allaart CF, et al
    Optimalization of the clinical pharmacogenetic model to predict methotrexate treatment response: the influence of the number of haplotypes of MTHFR 1298A-677C alleles on probability to respond.
    Ann Rheum Dis. 2009;68:1371.
    PubMed     Text format     Related articles   
    
    
    
64. VAN BENEDEN K , Coppieters K, Laroy W, De Keyser F, et al
    Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis.
    Ann Rheum Dis. 2009;68:1360-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. DUER-JENSEN A , Ejbjerg B, Albrecht-Beste E, Vestergaard A, et al
    Does low-field dedicated extremity MRI (E-MRI) reliably detect bone erosions in rheumatoid arthritis? A comparison of two different E-MRI units and conventional radiography with high-resolution CT scanning.
    Ann Rheum Dis. 2009;68:1296-302.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. MASAKI Y , Dong L, Kurose N, Kitagawa K, et al
    Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders.
    Ann Rheum Dis. 2009;68:1310-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. MEASE PJ , Hobbs K, Chalmers A, El-Gabalawy H, et al
    Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.
    Ann Rheum Dis. 2009;68:1247-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
68. SOKKA T , Kautiainen H, Pincus T, Toloza S, et al
    Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. SYVERSEN SW , Goll GL, van der Heijde D, Landewe R, et al
    Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a ten-year prospective study.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. BERNATSKY S , Renoux C, Suissa S
    Demyelinating events in rheumatoid arthritis after drug exposures.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. THURLINGS RM , Teng O, Vos K, Gerlag DM, et al
    Clinical response, pharmacokinetics, development of human anti-chimeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. COOMBS JH , Bloom BJ, Breedveld FC, Fletcher MP, et al
    Improved pain, physical functioning, and health status in rheumatoid arthritis patients treated with CP-690,550, an orally active Janus kinase (JAK)inhibitor: results from a randomized, double-blind, placebo-controlled trial.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. VERSTAPPEN SM , Bakker MF, Heurkens AH, van der Veen MJ, et al
    Adverse events and factors associated with toxicity in patients with early rheumatoid arthritis treated with methotrexate tight control therapy (the CAMERA study).
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. LOUIE GH , Ward MM
    Changes in the rates of joint surgery among patients with Rheumatoid Arthritis in California, 1983-2007.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. ALBRECHT K , Albert C, Lange U, Muller-Ladner U, et al
    Different effects of local cryogel and cold air physical therapy in wrist rheumatoid arthritis visualised by power Doppler ultrasound.
    Ann Rheum Dis. 2009;68:1234-5.
    PubMed     Text format     Related articles   
    
    
    
76. PETERS MJ , Nurmohamed MT, van Eijk IC, Verkleij CJ, et al
    Thrombin-activatable fibrinolysis inhibitor and its relation with inflammation in rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1232-3.
    PubMed     Text format     Related articles   
    
    
    
77. VARADE J , Ramon Lamas J, Rodriguez L, Fernandez-Arquero M, et al
    IL23R and IL12B genes: susceptibility analysis in rheumatoid arthritis.
    Ann Rheum Dis. 2009;68:1230-2.
    PubMed     Text format     Related articles   
    
    
    
78. PRINCE FH , Twilt M, Simon SC, van Rossum MA, et al
    When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis.
    Ann Rheum Dis. 2009;68:1228-9.
    PubMed     Text format     Related articles   
    
    
    
79. KAY J , Westhovens R
    Methotrexate: the gold standard without standardisation.
    Ann Rheum Dis. 2009;68:1081-2.
    PubMed     Text format     Related articles   
    
    
    
80. CANDON S , Gottenberg JE, Bengoufa D, Chatenoud L, et al
    Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity.
    Ann Rheum Dis. 2009;68:1208-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. HUSCHER D , Thiele K, Gromnica-Ihle E, Hein G, et al
    Dose-related patterns of glucocorticoid-induced side effects.
    Ann Rheum Dis. 2009;68:1119-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
82. MARTIN-TRUJILLO A , van Rietschoten JG, Timmer TC, Milena Rodriguez F, et al
    Loss of imprinting of IGF2 characterizes high IGF2mRNA-expressing type of Fibroblast-like Synoviocytes in Rheumatoid Arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. JUNGEL A , Ospelt C, Lesch M, Thiel M, et al
    Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. TENG YK , Tekstra J, Breedveld FC, Lafeber F, et al
    Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.
    Ann Rheum Dis. 2009;68:1075-7.
    PubMed     Text format     Related articles   
    
    
    
85. DOHN UM , Ostergaard M, Bird P, Boonen A, et al
    Tendency towards erosive regression on magnetic resonance imaging at 12 months in rheumatoid arthritis patients treated with rituximab.
    Ann Rheum Dis. 2009;68:1072-3.
    PubMed     Text format     Related articles   
    
    
    
86. SCOTT DL , Cope A
    New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
    Ann Rheum Dis. 2009;68:767-9.
    PubMed     Text format     Related articles   
    
    
    
87. CHEN DY , Chen YM, Ho WL, Chen HH, et al
    Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still's disease.
    Ann Rheum Dis. 2009;68:1074-5.
    PubMed     Text format     Related articles   
    
    
    
88. TENG YK , Levarht EW, Toes RE, Huizinga TW, et al
    Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
    Ann Rheum Dis. 2009;68:1011-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. NICKDEL MB , Conigliaro P, Valesini G, Hutchison S, et al
    Dissecting the contribution of innate and antigen-specific pathways to the breach of self-tolerance observed in a murine model of arthritis.
    Ann Rheum Dis. 2009;68:1059-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. LORENZI AR , Morgan TA, Anderson A, Catterall J, et al
    Thymic function in juvenile idiopathic arthritis.
    Ann Rheum Dis. 2009;68:983-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. VELOZO J , Aguilera S, Alliende C, Ewert P, et al
    Severe alterations in expression and localisation of {alpha}6{beta}4 integrin in salivary gland acini from patients with Sjogren syndrome.
    Ann Rheum Dis. 2009;68:991-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. KIEVIT W , Fransen J, Adang EM, Kuper HH, et al
    Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies.
    Ann Rheum Dis. 2009;68:844-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
93. AUGUSTSSON J , Neovius M, Cullinane-Carli C, Eksborg S, et al
    Rheumatoid arthritis (RA) patients treated with TNF-antagonists increase their participation in the work-force - potential for significant long-term indirect cost gains. Data from a population-based registry.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. BURR ML , Naseem H, Hinks A, Eyre S, et al
    PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian Population.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. VAN DER LINDEN MP , Boja R, Klarenbeek NB, Huizinga TW, et al
    Repair of joint erosions in rheumatoid arthritis: prevalence and patient characteristics in a large inception cohort.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. VAN TUYL LH , Boers M, Lems WF, Landewe RB, et al
    Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. VAN HULST LT , Fransen J, den Broeder AA, Grol R, et al
    Development of quality indicators for monitoring of the disease course in Rheumatoid Arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. KASTBOM A , Johansson M, Verma D, Soderkvist P, et al
    The CARD8 p.C10X polymorphism associates with the inflammatory activity in early rheumatoid arthritis.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. HELLGREN K , Iliadou A, Rosenquist R, Feltelius N, et al
    Rheumatoid arthritis, treatment with corticosteroids, and risk of malignant lymphomas - results from a case-control study.
    Ann Rheum Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. OROZCO G , Eyre S, Hinks A, Ke X, et al
     Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. FINCKH A , Ciurea A, Brulhart L, Kyburz D, et al
     Which subgroup of rheumatoid arthritis patients benefits from switching to rituximab versus alternative anti-TNF agents after previous failure to anti-TNF agent?
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. HIROHATA S , Miura Y, Tomita T, Yoshikawa H, et al
     Enhanced expression of mRNA for Kruppel-like factor 5 in CD34+ cells of the bone marrow in rheumatoid arthritis.
     Ann Rheum Dis. 2009;68:763-4.
     PubMed     Text format     Related articles   
     
     
     
103. BEJARANO V , Conaghan PG, Proudman SM, Buch MH, et al
     Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis.
     Ann Rheum Dis. 2009;68:761-3.
     PubMed     Text format     Related articles   
     
     
     
104. AGNEW-BLAIS JC , Coblyn JS, Katz JN, Anderson RJ, et al
     Measuring quality of care for rheumatic diseases using an electronic medical record.
     Ann Rheum Dis. 2009;68:680-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. ASKLING J , Baecklund E, Granath F, Geborek P, et al
     Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register.
     Ann Rheum Dis. 2009;68:648-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. PRINCE FH , Twilt M, ten Cate R, van Rossum MA, et al
     Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
     Ann Rheum Dis. 2009;68:635-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
107. RUPERTO N , Lovell DJ, Cuttica R, Woo P, et al
     Long-Term Efficacy and Safety of Infliximab plus Methotrexate for The Treatment of Polyarticular Course Juvenile Rheumatoid Arthritis: Findings from an Open-Label Treatment Extension.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. LIN HC , Chen SF, Lin HC, Chen YH, et al
     Increased risk of adverse pregnancy outcomes in women with Rheumatoid Arthritis: a nationwide population-based study.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. PATSOPOULOS NA , Ioannidis JP
     Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. SCHOELS M , Aletaha D, Smolen JS, Bijlsma JW, et al
     Follow-up standards and treatment targets in Rheumatoid Arthritis (RA): Results of a questionnaire at the EULAR 2008.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. HAUGEBERG G , Conaghan PG, Quinn M, Emery P, et al
     Bone loss in active early rheumatoid arthritis patients treated with infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a twelve-month randomized, double blind, placebo-controlled study.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. SCHERER HU , van der Linden MM, Kurreeman FA, Stoeken-Rijsbergen G, et al
     Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. ALTEN RE , Zerbini C, Jeka S, Irazoque F, et al
     Efficacy and safety of pamapimod in patients with active rheumatoid arthritis receiving stable methotrexate therapy.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. PAVELKA K , Jarosova K, Suchy D, Senolt L, et al
     Increasing the infliximab dose in rheumatoid arthritis patients: a randomized, double blind study failed to confirm its efficacy.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. SEROR R , Tubach F, Baron G, Guillemin F, et al
     Measure of function in rheumatoid arthritis: individualized or classical scales?
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. CHOY E , Sattar N
     Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions.
     Ann Rheum Dis. 2009;68:460-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. EMERY P , Van Vollenhoven R, Ostergaard M, Choy E, et al
     Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.
     Ann Rheum Dis. 2009;68:456-9.
     PubMed     Text format     Related articles   
     
     
     
118. NURMOHAMED MT , Dijkmans BA
     Dyslipidaemia, statins and rheumatoid arthritis.
     Ann Rheum Dis. 2009;68:453-5.
     PubMed     Text format     Related articles   
     
     
     
119. NARVAEZ J , Diaz-Torne C, Juanola X, Geli C, et al
     Rituximab therapy for refractory systemic-onset juvenile idiopathic arthritis.
     Ann Rheum Dis. 2009;68:607-8.
     PubMed     Text format     Related articles   
     
     
     
120. TYNJALA P , Vahasalo P, Honkanen V, Lahdenne P, et al
     Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
     Ann Rheum Dis. 2009;68:552-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. HAFSTROM I , Albertsson K, Boonen A, van der Heijde D, et al
     Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuatio
     Ann Rheum Dis. 2009;68:508-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. HORNEFF G , De Bock F, Foeldvari I, Girschick HJ, et al
     Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry.
     Ann Rheum Dis. 2009;68:519-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
123. NISHIMOTO K , Kochi Y, Ikari K, Yamamoto K, et al
     Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. JONES G , Sebba A, Gu J, Lowenstein MB, et al
     Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. KEKOW J , Moots RJ, Emery P, Durez P, et al
     Patient-reported outcomes improve with etanercept plus methotrexate in active early rheumatoid arthritis and the improvement is strongly associated with remission: The COMET trial.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. JORGENSEN KT , Pedersen BV, Jacobsen S, Biggar RJ, et al
     National cohort study of reproductive risk factors for rheumatoid arthritis in Denmark - a role for hyperemesis, gestational hypertension, and pre-eclampsia?
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. LUIME JJ , Colin EM, Hazes JM, Lubberts E, et al
     Does anti-MCV has additional value as serological marker in the diagnostic and prognostic work-up of patients with rheumatoid arthritis? A systematic review.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. DE MAN YA , Bakker-Jonges LE, Dufour-van den Goorbergh DB, Tillemans SP, et al
     Women with rheumatoid arthritis negative for anti-CCP and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody positive women autoantibody levels are not influenced by pregnancy.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. WARSTAT K , Hoberg M, Rudert M, Tsui S, et al
     TGF-{beta}1 and laminin-111 cooperate in the induction of IL-16 expression in synovial fibroblasts from rheumatoid arthritis patients.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. DAOUSSIS D , Panoulas VF, Antonopoulos I, John H, et al
     Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. CHARNI-BEN TABASSI N , Richardot P, Toh L, Marotte H, et al
     Circulating nitrated N-telopeptide of type III collagen (IIINys) as a biochemical marker of oxidative-related synovial tissue metabolism in rheumatoid arthritis.
     Ann Rheum Dis. 2009;68:451-2.
     PubMed     Text format     Related articles   
     
     
     
132. TEIXEIRA VH , Dieude P, Michou L, Migliorini P, et al
     Association study of the RANK locus in white European rheumatoid arthritis families.
     Ann Rheum Dis. 2009;68:448-9.
     PubMed     Text format     Related articles   
     
     
     
133. CUTOLO M , Otsa K, Paolino S, Yprus M, et al
     Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus.
     Ann Rheum Dis. 2009;68:446-7.
     PubMed     Text format     Related articles   
     
     
     
134. GOLDRING SR
     Periarticular bone changes in rheumatoid arthritis: pathophysiological implications and clinical utility.
     Ann Rheum Dis. 2009;68:297-9.
     PubMed     Text format     Related articles   
     
     
     
135. VORDENBAUMEN S , Ostendorf B, Sander O, Richter J, et al
     Continuation of anakinra despite the development of a pruritic rash in an otherwise refractory case of adult-onset Still's disease.
     Ann Rheum Dis. 2009;68:450-1.
     PubMed     Text format     Related articles   
     
     
     
136. CONIGLIARO P , Priori R, Bombardieri M, Alessandri C, et al
     Lymph node IL-18 expression in adult-onset Still's disease.
     Ann Rheum Dis. 2009;68:442-3.
     PubMed     Text format     Related articles   
     
     
     
137. AINOLA M , Li TF, Mandelin J, Hukkanen M, et al
     Involvement of a disintegrin and a metalloproteinase 8 (ADAM8) in osteoclastogenesis and pathological bone destruction.
     Ann Rheum Dis. 2009;68:427-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. WILDENBERG ME , Welzen-Coppens JM, van Helden-Meeuwsen CG, Bootsma H, et al
     Increased frequency of CD16+ monocytes and the presence of activated dendritic cells in salivary glands in primary Sjogren syndrome.
     Ann Rheum Dis. 2009;68:420-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
139. O'MAHONY R , Richards A, Deighton C, Scott D, et al
     Withdrawal of DMARDs in patients with Rheumatoid Arthritis: a systematic review and meta-analysis.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. DE JONG H , Berlo SE, Hombrink P, Otten HG, et al
     Cartilage proteoglycan aggrecan epitopes induce proinflammatory autoreactive T cell responses in rheumatoid arthritis and osteoarthritis.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. MELIS L , Vandooren B, Kruithof E, Jacques P, et al
     Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. MOMOHARA S , Ikari K, Mochizuki T, Kawamura K, et al
     Declining use of synovectomy surgery for patients with rheumatoid arthritis in Japan.
     Ann Rheum Dis. 2009;68:291-2.
     PubMed     Text format     Related articles   
     
     
     
143. VERVOORDELDONK MJ , Aalbers CJ, Tak PP
     Interferon beta for rheumatoid arthritis: new clothes for an old kid on the block.
     Ann Rheum Dis. 2009;68:157-8.
     PubMed     Text format     Related articles   
     
     
     
144. BOSSUYT X , Coenen D, Fieuws S, Verschueren P, et al
     Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
     Ann Rheum Dis. 2009;68:287-9.
     PubMed     Text format     Related articles   
     
     
     
145. MIMA T , Ishikawa S, Aoki C, Yoshio-Hoshino N, et al
     Interleukin 11 and paired immunoglobulin-like type 2 receptor alpha expression correlates with the number of joints with active arthritis in systemic juvenile idiopathic arthritis.
     Ann Rheum Dis. 2009;68:286-7.
     PubMed     Text format     Related articles   
     
     
     
146. D'ELIA HF , Bjurman C, Rehnberg E, Kvist G, et al
     Interleukin 6 and its soluble receptor in a central role at the neuroimmunoendocrine interface in Sjogren syndrome: an explanatory interventional study.
     Ann Rheum Dis. 2009;68:285-6.
     PubMed     Text format     Related articles   
     
     
     
147. MEIJER JM , Pijpe J, Vissink A, Kallenberg CG, et al
     Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment.
     Ann Rheum Dis. 2009;68:284-5.
     PubMed     Text format     Related articles   
     
     
     
148. SMOLEN JS , Aletaha D, Steiner G
     Does damage cause inflammation? Revisiting the link between joint damage and inflammation.
     Ann Rheum Dis. 2009;68:159-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. ISHIKAWA S , Mima T, Aoki C, Yoshio-Hoshino N, et al
     Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis.
     Ann Rheum Dis. 2009;68:264-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
150. SUGIYAMA D , Nishimura K, Tamaki K, Tsuji G, et al
     Impact of smoking as a risk factor for developing rheumatoid arthritis: A meta-analysis of observational studies.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. AHLMEN M , Svensson B, Albertsson K, Forslind K, et al
     Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. GOEKOOP-RUITERMAN YP , de Vries-Bouwstra JK, Kerstens PJ, Nielen MM, et al
     DAS-driven therapy versus routine care in patients with recent-onset active Rheumatoid Arthritis.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. GENOVESE MC , Breedveld FC, Emery P, Cohen S, et al
     Safety of biologic therapies following rituximab treatment in rheumatoid arthritis patients.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. NELL-DUXNEUNER V , Machold K, Stamm T, Eberl G, et al
     Autoantibody profiling in patients with very early rheumatoid arthritis - a follow-up study.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. VAN KUIJK AW , Wijbrandts CA, Vinkenoog M, Zheng TS, et al
     TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to TNF blockade.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. CURTIS JR , Beukelman T, Onofrei A, Cassell S, et al
     Elevated liver enzyme tests among rheumatoid arthritis and psoriatic arthritis patients treated with methotrexate and/or leflunomide.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. GONZALEZ-REY E , Gonzalez MA, Varela N, O'Valle F, et al
     Human adipose-derived mesenchymal stem cells reduce inflammatory and T-cell responses and induce regulatory T cells in vitro in rheumatoid arthritis.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. WESTHOVENS R , Robles M, Ximenes AC, Nayiager S, et al
     Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors.
     Ann Rheum Dis. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. STAMP LK , O'Donnell JL, Chapman PT, Barclay ML, et al
     Lack of association between HLA-G 14 bp insertion/deletion polymorphism and response to long-term therapy with methotrexate response in rheumatoid arthritis.
     Ann Rheum Dis. 2009;68:154-5.
     PubMed     Text format     Related articles   
     
     
     
160. DE BANDT M , Saint-Marcoux B
     Tocilizumab for multirefractory adult-onset Still's disease.
     Ann Rheum Dis. 2009;68:153-4.
     PubMed     Text format     Related articles   
     
     
     
161. BOERS M
     Just released from the ASAS factory! First steps towards a disease activity score for ankylosing spondylitis.
     Ann Rheum Dis. 2009;68:1-2.
     PubMed     Text format     Related articles   
     
     
     
162. POTTER C , Hyrich KL, Tracey A, Lunt M, et al
     Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
     Ann Rheum Dis. 2009;68:69-74.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. HULTQVIST M , Nandakumar KS, Bjorklund U, Holmdahl R, et al
     The novel small molecule drug Rabeximod is effective in reducing disease severity of mouse models of autoimmune disorders.
     Ann Rheum Dis. 2009;68:130-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. BLOM AM , Nandakumar KS, Holmdahl R
     C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice.
     Ann Rheum Dis. 2009;68:136-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. BRENTANO F , Ospelt C, Stanczyk J, Gay RE, et al
     Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis.
     Ann Rheum Dis. 2009;68:143-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. KARAISKOS D , Mavragani CP, Makaroni S, Zinzaras E, et al
     Stress, coping strategies and social support in patients with primary Sjogren's syndrome prior to disease onset: a retrospective case-control study.
     Ann Rheum Dis. 2009;68:40-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. ZHANG W , Doherty M, Leeb BF, Alekseeva L, et al
     EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT.
     Ann Rheum Dis. 2009;68:8-17.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
168. RATERMAN HG , van Eijk IC, Voskuyl AE, Peters MJ, et al
     The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross sectional study.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. HAMMER HB , Odegard S, Syversen SW, Landewe R, et al
     Calprotectin (a major S100 leukocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. PINCUS T , Luta G, Swearingen CJ
     Efficacy of 1-4 mg per day of prednisone in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled withdrawal clinical trial.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. SCHIFF MH , Pritchard C, Huffstutter JE, Rodriguez-Valverde V, et al
     The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-TNF therapy or were directly switched to abatacept: the ARRIVE trial.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. DOUGADOS M , Schmidely N, Le Bars M, Lafosse C, et al
     Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. KEYSTONE EC , Genovese MC, Klareskog L, Hsia EC, et al
     Golimumab, a human antibody to TNF-{alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate: The GO-FORWARD Study.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. SALLIOT C , van der Heijde D
     Long term safety of Methotrexate monotherapy in rheumatoid arthritis patients: A systematic literature research.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. COLLINS CE , La DT, Yang HT, Massin F, et al
     Elevated synovial expression of triggering receptor expressed on myeloid cells-1 (TREM-1) in patients with septic arthritis or rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. GOSSEC L , Dougados M, Rincheval N, Balanescu A, et al
     The elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. KATCHAMART W , Trudeau J, Phumethum V, Bombardier C, et al
     The efficacy and toxicity of Methotrexate (MTX) monotherapy vs. MTX combination therapy with non-biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis: A systematic review and metaanalysis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. SIMON TA , Smitten AL, Franklin J, Askling J, et al
     Malignancies in the rheumatoid arthritis abatacept clinical development program: An epidemiological assessment.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. TSUKAHARA S , Ikari K, Sato E, Yamanaka H, et al
     A polymorphism in the gene encoding the Fcgamma IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis.
     Ann Rheum Dis. 2008;67:1791-2.
     PubMed     Text format     Related articles   
     
     
     
180. CONTI F , Ceccarelli F, Priori R, Iagnocco A, et al
     Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
     Ann Rheum Dis. 2008;67:1787-90.
     PubMed     Text format     Related articles   
     
     
     
181. LEDEN I , Theander J, Svensson B
     Small joint ankylosis in rheumatoid arthritis: a vanishing phenomenon or a pathogenetic clue, or both?
     Ann Rheum Dis. 2008;67:1786-7.
     PubMed     Text format     Related articles   
     
     
     
182. FEITSMA AL , van der Helm-van Mil AH, Huizinga TW, de Vries RR, et al
     Protection against rheumatoid arthritis by HLA: nature and nurture.
     Ann Rheum Dis. 2008;67 Suppl 3:iii61-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. GABRIEL SE
     Why do people with rheumatoid arthritis still die prematurely?
     Ann Rheum Dis. 2008;67 Suppl 3:iii30-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. EKLOW C , Makrygiannakis D, Backdahl L, Padyukov L, et al
     Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells.
     Ann Rheum Dis. 2008;67:1742-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. ETTINGER R , Kuchen S, Lipsky PE
     Interleukin 21 as a target of intervention in autoimmune disease.
     Ann Rheum Dis. 2008;67 Suppl 3:iii83-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. SHEEDY FJ , O'Neill LA
     Adding fuel to fire: microRNAs as a new class of mediators of inflammation.
     Ann Rheum Dis. 2008;67 Suppl 3:iii50-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
187. VISSER K , Katchamart W, Loza E, Martinez-Lopez JA, et al
     Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. VISSER K , van der Heijde D
     Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. LUKAS C , Landewe RB, Fatenejad S, van der Heijde DM, et al
     Subtle changes in individual joints result in both positive and negative change scores in a patient: Results from a clinical trial in patients with rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. RADSTAKE TR , Svenson M, Eijsbouts AM, van den Hoogen FH, et al
     Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. THABET MM , Huizinga TW, Marques RB, Stoeken-Rijsbergen G, et al
     The contribution of Fc gamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA positive rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. BONGARTZ T , Warren FC, Mines D, Matteson EL, et al
     Etanercept therapy in rheumatoid arthritis and the risk of malignancies. A systematic review and individual patient data meta-analysis of Randomized Controlled Trials.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. NISHIMOTO N , Miyasaka N, Yamamoto K, Kawai S, et al
     Long-term safety and efficacy of tocilizumab, an anti-interleukin-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. MOLLER DOHN U , Boonen A, Hetland ML, Hansen MS, et al
     Erosive progression is minimal, but erosion healing rare, in rheumatoid arthritis patients treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. RADOVITS BJ , Kievit W, Fransen J, van der Laar MA, et al
     Influence of age on the outcome of anti-TNF{alpha}therapy in rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. KURIYA B , Cheng CK, Chen HM, Bykerk VP, et al
     Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. MATHIEUX R , Marotte H, Battistini L, Sarrazin A, et al
     Early occupational therapy program increases hand grip strength at 3 months: results from a randomized blind controlled study in early Rheumatoid Arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. SMOLEN JS , Landewe RB, Mease PJ, Brzezicki J, et al
     Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Active Rheumatoid Arthritis: The RAPID 2 Study.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. FLEISCHMANN R , Vencovsky J, van Vollenhoven R, Borenstein D, et al
     Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. OWCZARCZYK K , Hellmann M, Fliedner G, Rohrs T, et al
     Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
     Ann Rheum Dis. 2008;67:1648-9.
     PubMed     Text format     Related articles   
     
     
     
201. PERRY ME , Chee MM, Ferrell WR, Lockhart JC, et al
     Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis.
     Ann Rheum Dis. 2008;67:1646-7.
     PubMed     Text format     Related articles   
     
     
     
202. GONZALEZ-GAY MA , Garcia-Unzueta MT, Berja A, Vazquez-Rodriguez TR, et al
     Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
     Ann Rheum Dis. 2008;67:1644-6.
     PubMed     Text format     Related articles   
     
     
     
203. BOS WH , Nielen MM, Dijkmans BA, van Schaardenburg D, et al
     Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion.
     Ann Rheum Dis. 2008;67:1642.
     PubMed     Text format     Related articles   
     
     
     
204. SMOLEN JS , Weinblatt ME
     When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
     Ann Rheum Dis. 2008;67:1497-8.
     PubMed     Text format     Related articles   
     
     
     
205. ALBERS HM , Kurreeman FA, Houwing-Duistermaat JJ, Brinkman DM, et al
     The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis.
     Ann Rheum Dis. 2008;67:1578-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. DASS S , Bowman SJ, Vital EM, Ikeda K, et al
     Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.
     Ann Rheum Dis. 2008;67:1541-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. POLZER K , Baeten D, Soleiman A, Distler J, et al
     Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints.
     Ann Rheum Dis. 2008;67:1610-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
208. UHLIG T , Kvien TK, Pincus T
     Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. SMOLEN JS , van der Heijde DM, Aletaha D, Xu S, et al
     Progression of radiographic joint damage in rheumatoid arthritis: Independence of erosions and joint space narrowing.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. AUGER I , Balandraud N, Rak J, Lambert N, et al
     New autoantigens in rheumatoid arthritis: screening 8268 protein arrays with RA patients' sera.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. CARLENS C , Jacobsson LT, Brandt L, Cnattingius S, et al
     Perinatal characteristics, early life infections, and later risk of rheumatoid arthritis and juvenile idiopathic arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. TOLUSSO B , Frezza D, Mattioli C, Fedele A, et al
     Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with Rheumatoid Arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. CANETE JD , Suarez B, Hernandez MV, Sanmarti R, et al
     Influence of variants of Fc{gamma}receptors IIA and IIIA on the ACR and EULAR responses to anti-TNF{alpha} therapy in rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. VAN DER KOOIJ SM , le Cessie S, Goekoop-Ruiterman YP, De Vries-Bouwstra JK, et al
     Clinical and radiological efficacy of initial versus delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. WONG M , Oakley SP, Young L, Jiang B, et al
     Infliximab improves vascular stiffness in patients with rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. KARONITSCH T , Aletaha D, Boers M, Bombardieri S, et al
     Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis.
     Ann Rheum Dis. 2008;67:1365-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. ALETAHA D , Landewe R, Karonitsch T, Bathon J, et al
     Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
     Ann Rheum Dis. 2008;67:1360-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. HALPERN MT , Cifaldi MA, Kvien TK
     Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. NIEDBALA W , Cai B, Wei X, Patakas A, et al
     Interleukin 27 attenuates collagen-induced arthritis.
     Ann Rheum Dis. 2008;67:1474-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. MOUTSOPOULOS NM , Katsifis GE, Angelov N, Leakan RA, et al
     Lack of efficacy of etanercept in Sjogren syndrome correlates with failed suppression of tumour necrosis factor alpha and systemic immune activation.
     Ann Rheum Dis. 2008;67:1437-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. ALLIENDE C , Kwon YJ, Brito M, Molina C, et al
     Reduced sulfation of muc5b is linked to xerostomia in patients with Sjogren syndrome.
     Ann Rheum Dis. 2008;67:1480-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
222. ROSSOL M , Pierer M, Arnold S, Keyszer G, et al
     Homozygosity for DNASE2 single-nucleotide polymorphisms in the 5' regulatory region is associated with rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. HOFF M , Kvien TK, Kalvesten J, Elden A, et al
     Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: Explorative analyses from the PREMIER study.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
224. COMBE B , Codreanu C, Fiocco U, Gaubitz M, et al
     Efficacy, safety, and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomized two-year study.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. BUCH MH , Boyle DL, Rosengren S, Saleem B, et al
     Mode of action of abatacept in rheumatoid arthritis patients having failed TNF blockade: a histological, gene expression and dynamic MRI pilot study.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. DALBETH N , Smith T, Gray S, Doyle A, et al
     Cellular characterization of magnetic resonance imaging (MRI) bone edema in rheumatoid arthritis; implications for pathogenesis of erosive disease.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. ROELOFS MF , Wenink MH, Brentano F, Abdollahi-Roodsaz S, et al
     Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4 mediated synovial inflammation in rheumatoid arthritis (RA).
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. PORTER D
     Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
     Ann Rheum Dis. 2008;67:1356.
     PubMed     Text format     Related articles   
     
     
     
229. MARTINEZ A , Varade J, Lamas JR, Fernandez-Arquero M, et al
     GDF5 Polymorphism associated with osteoarthritis: risk for rheumatoid arthritis.
     Ann Rheum Dis. 2008;67:1352-3.
     PubMed     Text format     Related articles   
     
     
     
230. FREESTON JE , Brown AK, Hensor EM, Emery P, et al
     Extremity magnetic resonance imaging assessment of synovitis (without contrast) in rheumatoid arthritis may be less accurate than power Doppler ultrasound.
     Ann Rheum Dis. 2008;67:1351.
     PubMed     Text format     Related articles   
     
     
     
231. RAZA K , Mullazehi M, Salmon M, Buckley CD, et al
     Anti-collagen type II antibodies in patients with very early synovitis.
     Ann Rheum Dis. 2008;67:1354-5.
     PubMed     Text format     Related articles   
     
     
     
232. LEKHARAJU V , Chattopadhyay C
     Efficacy of rituximab in Felty's syndrome.
     Ann Rheum Dis. 2008;67:1352.
     PubMed     Text format     Related articles   
     
     
     
233. HARDY R , Rabbitt EH, Filer A, Emery P, et al
     Local and systemic glucocorticoid metabolism in inflammatory arthritis.
     Ann Rheum Dis. 2008;67:1204-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. BOS WH , Ursum J, de Vries N, Bartelds GM, et al
     The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels.
     Ann Rheum Dis. 2008;67:1347-50.
     PubMed     Text format     Related articles    Abstract available
     
     
     
235. VAN DER HEIJDE D , Landewe R, van Vollenhoven R, Fatenejad S, et al
     Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.
     Ann Rheum Dis. 2008;67:1267-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
236. BANAL F , Dougados M, Combescure C, Gossec L, et al
     Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. LEOMBRUNO JP , Einarson TR, Keystone EC
     The safety of anti-Tumor Necrosis Factor treatments in rheumatoid arthritis: meta and exposure adjusted pooled analyses of serious adverse events.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
238. WIJBRANDTS CA , van Leuven SI, Boom HD, Gerlag DM, et al
     Sustained changes in lipid profile and macrophage migration inhibitory factor (MIF) levels after anti-TNF therapy in rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. HALVORSEN EH , Haavardsholm EA, Pollmann S, Boonen A, et al
     Serum IgG antibodies to Peptidylarginine Deiminase 4 predict radiographic progression in rheumatoid arthritis patients treated with TNF-{alpha} blocking agents.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. VAN DER HEIJDE D , Burmester GR, Melo-Gomes JR, Codreanu C, et al
     Inhibition of radiographic progression with combination etanercept and methotrexate in patients with moderately active rheumatoid arthritis previously treated with monotherapy.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
241. MAROTTE H , Gineyts E, Miossec P, Delmas PD, et al
     Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
242. RADOVITS BJ , Popa-Diaconu DA, Popa C, Eijsbouts A, et al
     Disease activity as a risk factor for myocardial infarction in Rheumatoid Arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
243. ZHANG B , Lavalley M, Felson DT
     The sensitivity to change for Lower Disease Activity is greater than for Higher Disease Activity in rheumatoid arthritis trials.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
244. VAN HALM VP , Peters MJ, Voskuyl AE, Boers M, et al
     Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease, a cross sectional study. The CARRE Investigation.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
245. GUTHRIE KA , Tishkevich NR, Nelson JL
     Non inherited maternal HLA antigens in susceptibility to familial rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
246. STAVROPOULOS-KALINOGLOU A , Metsios GS, Panoulas VF, Douglas KM, et al
     Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
247. CARTER JD , Gerard HC, Hudson AP
     Psoriasiform lesions induced by tumour necrosis factor antagonists: a skin-deep medical conundrum.
     Ann Rheum Dis. 2008;67:1181-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
248. PESSLER F , Dai L, Diaz-Torne C, Gomez-Vaquero C, et al
     The synovitis of "non-inflammatory" orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis.
     Ann Rheum Dis. 2008;67:1184-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
249. GERLONI V , Pontikaki I, Gattinara M, Fantini F, et al
     Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
     Ann Rheum Dis. 2008;67:1145-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
250. MAGNI-MANZONI S , Pistorio A, Labo E, Viola S, et al
     A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis.
     Ann Rheum Dis. 2008;67:1159-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
251. TROCME C , Marotte H, Baillet A, Pallot-Prades B, et al
     Apolipoprotein A-I and platelet factor 4 are biomarkers for Infliximab response in rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
252. VAN DER KOOIJ SM , Goekoop-Ruiterman YP, De Vries-Bouwstra JK, Guler-Yuksel M, et al
     Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent onset rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
253. JICK SS , Choi H, Li L, McInnes IB, et al
     Hyperlipidemia, statin use and the risk of developing rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
254. HOLLIS-MOFFATT JE , Merriman ME, Rodger RA, Rowley KA, et al
     Evidence for association of an interleukin-23 receptor variant independent of the R381Q variant with rheumatoid arthritis.
     Ann Rheum Dis. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
255. SYED RH , Gilliam BE, Moore TL
     Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
     Ann Rheum Dis. 2008;67:1049-51.
     PubMed     Text format     Related articles   
     
     
     
256. VARELA DC , Quintana G, Somers EC, Rojas-Villarraga A, et al
     Delayed lupus nephritis.
     Ann Rheum Dis. 2008;67:1044-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
257. THURLINGS RM , Vos K, Wijbrandts CA, Zwinderman AH, et al
     Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response.
     Ann Rheum Dis. 2008;67:917-25.
     PubMed     Text format     Related articles    Abstract available
     
     
     
258. HALDORSEN K , Moen K, Jacobsen H, Jonsson R, et al
     Exocrine function in primary Sjogren syndrome: natural course and prognostic factors.
     Ann Rheum Dis. 2008;67:949-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
259. SOFAT N , Venables PJ
     Is Sjogren myelopathy Devic disease?
     Ann Rheum Dis. 2008;67:730-1.
     PubMed     Text format     Related articles   
     
     
     
260. CEPEDA EJ , Williams FM, Ishimori ML, Weisman MH, et al
     The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease.
     Ann Rheum Dis. 2008;67:710-2.
     PubMed     Text format     Related articles    Abstract available
     
     
     
261. GELINCK LB , van der Bijl AE, Beyer WE, Visser LG, et al
     The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.
     Ann Rheum Dis. 2008;67:713-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
262. HIDA A , Akahoshi M, Takagi Y, Ashizawa K, et al
     Prevalence of Sjogren syndrome among Nagasaki atomic bomb survivors.
     Ann Rheum Dis. 2008;67:689-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     
263. GARCIA S , Bodano A, Pablos JL, Gomez-Reino JJ, et al
     Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts.
     Ann Rheum Dis. 2008;67:631-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
264. PATTERSON AM , Cartwright A, David G, Fitzgerald O, et al
     Differential expression of syndecans and glypicans in chronically inflamed synovium.
     Ann Rheum Dis. 2008;67:592-601.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: